This is a demo store. No orders will be fulfilled.

Atenolol - 10mM in DMSO, high purity , CAS No.29122-68-7, Beta-1 adrenergic receptor antagonist

In stock
Item Number
A423026
Grouped product items
SKU Size
Availability
Price Qty
A423026-1ml
1ml
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$69.90

β 1 Adrenoceptor antagonist

View related series
Compound libraries (12325)

Basic Description

Synonyms atenolol | 29122-68-7 | Tenormin | Prenormine | Blokium | Myocord | Normiten | (RS)-Atenolol | Duraatenolol | Betacard | Corotenol | Tenormine | Atehexal | Betablok | Cuxanorm | Juvental | Selobloc | Tenoblock | Antipressan | Atenblock | Farnormin | Internolol | Premorine | Vericordin | Anselol | Atcardi
Specifications & Purity Moligand™, 10mM in DMSO
Biochemical and Physiological Mechanisms Selective β1-adrenoceptor antagonist; antihypertensive; antianginal; antiarrhythmic.β 1 Adrenoceptor antagonist. K i values are 1.14 and 48.7 μM for receptor subtypes β 1 and β 2 , respectively. Antihypertensive. Limited ability to cross the blood-brain b
Storage Temp Store at -80°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade Moligand™
Action Type ANTAGONIST
Mechanism of action Beta-1 adrenergic receptor antagonist
Product Description

(RS)-Atenolol is a cardioselective β-adrenergic blocker. It is considered to be antihypertensive, antianginal, and antiarrhythmic. (RS)-Atenolol is an inhibitor of β1-AR and β2-AR.
An inhibitor of β1-AR and β2-AR.Atenolol is a β-adrenergic blocker and used in the management of hypertension. Atenolol has antianginal and antiarrhythmic properties.

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Benzenoids
Class Benzene and substituted derivatives
Subclass Phenylacetamides
Intermediate Tree Nodes Not available
Direct Parent Phenylacetamides
Alternative Parents Phenoxy compounds  Phenol ethers  Alkyl aryl ethers  Secondary alcohols  Primary carboxylic acid amides  Amino acids and derivatives  1,2-aminoalcohols  Dialkylamines  Organopnictogen compounds  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular Framework Aromatic homomonocyclic compounds
Substituents Phenylacetamide - Phenoxy compound - Phenol ether - Alkyl aryl ether - 1,2-aminoalcohol - Amino acid or derivatives - Carboxamide group - Secondary alcohol - Primary carboxylic acid amide - Carboxylic acid derivative - Secondary amine - Secondary aliphatic amine - Ether - Organic nitrogen compound - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Organic oxide - Carbonyl group - Organopnictogen compound - Amine - Organic oxygen compound - Alcohol - Aromatic homomonocyclic compound
Description This compound belongs to the class of organic compounds known as phenylacetamides. These are amide derivatives of phenylacetic acids.
External Descriptors monocarboxylic acid amide - ethanolamines - propanolamine

Product Properties

ALogP 0.2

Associated Targets(Human)

ADRB1 Tclin Beta-1 adrenergic receptor (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
MAOB Tclin Monoamine oxidase B (8835 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR4 Tclin Serotonin 4 (5-HT4) receptor (2068 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Associated Targets(non-human)

Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mc4r Melanocortin receptor 4 (1205 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Ltc4s Leukotriene C4 synthase (1 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Abcb1b P-glycoprotein 1 (174 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Escherichia coli (133304 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Pneumocystis carinii (749 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania infantum (5912 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trypanosoma brucei (78846 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Entamoeba histolytica (2676 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Cryptosporidium parvum (1150 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Candida albicans (78123 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania amazonensis (3813 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania donovani (89745 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania major (2877 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania mexicana (936 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trichomonas vaginalis (2376 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mus musculus (284745 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trypanosoma brucei rhodesiense (7991 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
MDCK (10148 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Urease (750 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
pfk 6-phospho-1-fructokinase (7870 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Brain (1 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Plasma (328 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Serum (58 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Whole blood (71 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Glra2 Glycine receptor (1745 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Dipeptidyl peptidase 3 (24 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Names and Identifiers

IUPAC Name 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
INCHI InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
InChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
Smiles CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
Isomeric SMILES CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
WGK Germany 2
RTECS AC3600000
Molecular Weight 266.34
Reaxy-Rn 2739235
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=2739235&ln=

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Chemical and Physical Properties

Melt Point(°C) 151-155℃
Molecular Weight 266.340 g/mol
XLogP3 0.200
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 8
Exact Mass 266.163 Da
Monoisotopic Mass 266.163 Da
Topological Polar Surface Area 84.600 Ų
Heavy Atom Count 19
Formal Charge 0
Complexity 263.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 1
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Citations of This Product

1. Juan Luo, Bowen Zhou, Chenjun Dong, Rongrong He, Yuling Zhang, Tao He.  (2024)  Effect of substrate morphology on characteristics of layer-by-layer self-assembly nanofiltration membrane for micropollutants removal.  DESALINATION,  574  (117229). 
2. Lianxu Wang, Zhen Lei, Sining Yun, Xiaohuan Yang, Rong Chen.  (2024)  Quantitative structure-biotransformation relationships of organic micropollutants in aerobic and anaerobic wastewater treatments.  SCIENCE OF THE TOTAL ENVIRONMENT,  912  (169170). 
3. Xiancheng Wan, Huili Wang, Qiuhui Qian, Jin Yan.  (2023)  MiR-133b as a crucial regulator of TCS-induced cardiotoxicity via activating β-adrenergic receptor signaling pathway in zebrafish embryos.  ENVIRONMENTAL POLLUTION,  334  (122199). 
4. Jun Young Kim, Kang Hoon Lee, Jae Won Lee, Imtiaz Afzal Khan, Jong-Oh Kim.  (2023)  Structural and performance variation of PES/PVDF membranes after exposure to the pretreated feed water of CECs.  CHEMOSPHERE,  335  (139096). 
5. Yinqiao Zhang, Yang Guo, Jingyun Fang, Kaiheng Guo, Gang Yu, Yujue Wang.  (2023)  Characterization of UV/chlorine process for micropollutant abatement by probe compound-based kinetic models.  WATER RESEARCH,  237  (119985). 
6. Qian Wang, Can He, Yue Shan, Zhongguo Zhang, Jiuyi Li.  (2023)  Catalytic ozonation of atenolol by Mn-Ce@Al2O3 catalysts: Efficiency, mechanism and degradation pathways.  Journal of Environmental Chemical Engineering,  11  (109444). 
7. Li Chen, Tahir Maqbool, Ghazanfar Nazir, Congyu Hou, Yanna Xu, Yulong Yang, Xihui Zhang.  (2023)  Peroxymonosulfate activated by composite ceramic membrane for the removal of pharmaceuticals and personal care products (PPCPs) mixture: Insights of catalytic and noncatalytic oxidation.  WATER RESEARCH,  229  (119444). 
8. Jieqing Feng, Qisheng Zhong, Ting Zhou.  (2022)  Online Pressure Change Focusing-Supercritical Fluid Selective Extraction Chromatography for Analyzing Chiral Drugs in Microliter-Scale Plasma Samples.  ANALYTICAL CHEMISTRY,  94  (46): (16222–16230). 
9. Wenqi Diao, Jin Yan, Xuedong Wang, Qiuhui Qian, Huili Wang.  (2023)  Mechanisms regarding cardiac toxicity triggered by up-regulation of miR-144 in larval zebrafish upon exposure to triclosan.  JOURNAL OF HAZARDOUS MATERIALS,  443  (130297). 
10. Yafang Zhang, Shuning Yang, Linsheng Wei, Xiaoyang Zhao, Xiangdong Lu.  (2022)  Degradation characteristics of p-nitrophenol and atenolol by carbon nitride modified by graphene quantum dots.  ENVIRONMENTAL TECHNOLOGY,     
11. Kun Chen, Shengqiu Liu, Wei Zhu, Panchao Yin.  (2022)  Surface Engineering Promoted Insulin-Sensitizing Activities of Sub-Nanoscale Vanadate Clusters through Regulated Pharmacokinetics and Bioavailability.  Small,  18  (40): (2203957). 
12. Jian Zhao, Shangbiao Fang, Weixiao Qi, Huijuan Liu, Jiuhui Qu.  (2022)  Do NH4+-N and AOB affect atenolol removal during simulated riverbank filtration?.  CHEMOSPHERE,  301  (134653). 
13. Long Jiang, Tao Jing, Xiantao Shen.  (2022)  Molecularly imprinted wax.  Journal of Materials Chemistry B,  10  (35): (6742-6751). 
14. Di Liu, Yunning Chen, Renquan Guan, Jie Zhao, Huimin Jin, Siyi Zhang, Qingkun Shang.  (2022)  Photocatalytic performance of heterojunction S-Tyr-NDI-Tyr/TiO2 formed by self-assembled naphthalimide derivatives and titanium dioxide.  CHEMOSPHERE,  296  (134046). 
15. Ming Yan, Yilin Wu, Rongxin Lin, Faguang Ma, Zhongyi Jiang.  (2021)  Multilevel/hierarchical nanocomposite-imprinted regenerated cellulose membranes for high-efficiency separation: a selective recognition method with Au/PDA-loaded surface.  Environmental Science-Nano,  (7): (1978-1991). 
16. Yijie Liu, Xianzhe Meng, Chao Li, Yifan Gong, Juan Wang, Jiang Bo.  (2020)  Electrochemical Degradation of Pharmaceuticals Using Ti/SnO2-Sb2O5-IrO2-RuO2 Anode: Electrode Properties, Performance and Contributions of Diverse Reactive Species.  JOURNAL OF THE ELECTROCHEMICAL SOCIETY,  167  (14): (143503). 
17. Yifei Wang, Jing Niu, Xin Gao, Yanlin Zhang.  (2020)  Synergetic tuning of photocatalytic activity and photostability of Ag3PO4 via yttrium doping, carbon quantum dots and BiVO4 for atenolol degradation.  APPLIED SURFACE SCIENCE,  533  (147458). 
18. Xiuping Sun, Guifang Pan, Haiqiang Qi, Zhirong Sun.  (2020)  Dip-coating prepared nickel-foam composite cathodes with hydrophobic layer for atenolol elimination in electro-Fenton system.  JOURNAL OF ELECTROANALYTICAL CHEMISTRY,  856  (113725). 
19. Pan Li, Huan He, Dongyue Lin, Liangbao Yang.  (2019)  Highly sensitive detection of an antidiabetic drug as illegal additives in health products using solvent microextraction combined with surface-enhanced Raman spectroscopy.  ANALYST,  144  (24): (7406-7411). 
20. Shucheng Sun, Yujia Wang, Xin Liu, Rao Fu, Li Yang.  (2018)  Rapid and sensitive tapered-capillary microextraction combined to on-line sample stacking-capillary electrophoresis for extraction and quantification of two beta-blockers in human urine.  TALANTA,  180  (90). 
21. Yunhai Zhang, Haoran Mao, Qing Ma, Zihao Chen, Hao Wang, Anlin Xu, Yongjun Zhang.  (2024)  A QSAR prediction model for adsorption of organic contaminants on microplastics: Dubinin-Astakhov plus linear solvation energy relationships.  SCIENCE OF THE TOTAL ENVIRONMENT,  930  (172801). 
22. Wen-Long Wang, Zi-Bo Jing, Yi-Lin Zhang, Qian-Yuan Wu, Jörg E. Drewes, Min-Yong Lee, Uwe Hübner.  (2024)  Assessing the Chemical-Free Oxidation of Trace Organic Chemicals by VUV/UV as an Alternative to Conventional UV/H2O2.  ENVIRONMENTAL SCIENCE & TECHNOLOGY,  58  (16): (7113-7123). 
23. Qiao-Lai Wang, Pei-Xi Zhang, Rui Shen, Meng Xu, Liang Han, Xuan Shi, Zi-Rui Zhou, Jing-Yi Yang, Jie-Qing Liu.  (2024)  Determination of arbutin in vitro and in vivo by LC-MS/MS: Pre-clinical evaluation of natural product arbutin for its early medicinal properties.  JOURNAL OF ETHNOPHARMACOLOGY,  330  (118232). 
24. Tingming Ye, QingJi Wang, Jing Qi, Baiwen Ma, Tao Lyu, Chengzhi Hu, Mathias Ulbricht, Huijuan Liu.  (2025)  Exploring advanced and sustainable bioaugmentation-enhanced ultrafiltration processes for the removal of emerging contaminants.  JOURNAL OF MEMBRANE SCIENCE,  720  (123784). 
25. Xiaohong Ding, Ruiqiang Chen, Jie Xu, Jiapeng Hu, Zhixuan Zhao, Cheng Zhang, Longhui Zheng, Huanyu Cheng, Zixiang Weng, Lixin Wu.  (2025)  Highly stable scalable production of porous graphene-polydopamine nanocomposites for drug molecule sensing.  TALANTA,  282  (126990). 
26. Tong Li, Hui Li, Jia Chen, Yongliang Yu, Shuai Chen, Jianhua Wang, Hongdeng Qiu.  (2024)  Histidine-modified pillar[5]arene-functionalized mesoporous silica materials for highly selective enantioseparation.  JOURNAL OF CHROMATOGRAPHY A,  1727  (465011). 
27. Tao Yang, Ge Zeng, Maoju Jiang, Peng Su, Chenlong Liu, Qixiao Lv, Wenqi Li, Xiangyang Hou, Juan Li.  (2024)  Matching periodate peak absorbance by far UVC at 222 nm promotes the degradation of micropollutants and energy efficiency.  JOURNAL OF HAZARDOUS MATERIALS,  476  (134978). 
28. Bei Ye, Wen-Long Wang, Chen-Xin Xu, Wei Wang, Min-Yong Lee, Shu-Yan Zhan, Qian-Yuan Wu.  (2024)  Ozone-microbubble-enhanced oxidation of pharmaceuticals and personal care products in municipal secondary effluents.  Journal of Environmental Chemical Engineering,  12  (114421). 
29. Xiang Yuqian, Huang Yu, Yan Xiaohui, Zhu Zhipeng, Wu Dapeng, Gao Peng, Li Jiulong.  (2024)  Retention and Selectivity on Hydrophilic Interaction Liquid Chromatography Columns Modified with Polyethylene Glycol of Different Chain Length.  CHROMATOGRAPHIA,    (1-13). 

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.